Literature DB >> 9585133

Differential regulation of N- and Q-type Ca2+ channels by cyclic nucleotides and G-proteins.

S Kaneko1, A Akaike, M Satoh.   

Abstract

Voltage-dependent Ca2+ channels play a central role in controlling neurotransmitter release at the synapse. They can be inhibited by certain G-protein-coupled receptors, acting by a pathway delimited to the membrane. In addition, modulation of Ca2+ channel activity by protein kinases also contributes to the dynamic regulation of neuronal physiology. Recently, differences in these modulations between Ca2+ channel subtypes have been shown in several neuronal preparations. Here we show that two types of presynaptic Ca2+ channel (N-type and Q-type) are differentially regulated by cAMP and G-proteins using a Xenopus oocyte expression system. Treatment to increase cytosolic cAMP concentration with forskolin and 3-isobutyl-1-methylxanthine (IBMX) markedly potentiated Q-type channel current, and the enhancement was reversed by protein kinase A inhibitors. Much smaller enhancement was observed in N-type channel current after the cAMP elevation. When large depolarizing prepulse was applied to the oocytes for evaluation of the tonic inhibition of Ca2+ channels by intrinsic G-protein activity, N-type channel current elicited a large prepulse facilitation but Q-type channels did not. The tonic inhibition of N-type channels was abolished by an intracellular perfusion with a 'cut-open' recording configuration, or by co-expression with G(alpha o). When kappa opioid receptors were co-expressed and stimulated with agonists, depolarization-resistant inhibition was more apparent in Q-type channels than in N-type channels. These results suggest that Q-type channels are more susceptible to the protein kinase A-mediated facilitation than N-type channels, and that activity of N-type channels can be more highly regulated in a voltage-dependent manner by G(betagamma) than that of Q-type channels. These differences may account for the selective regulation of neurotransmitter release by these Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585133     DOI: 10.1016/s0024-3205(98)00104-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release.

Authors:  M Okada; D J Nutt; T Murakami; G Zhu; A Kamata; Y Kawata; S Kaneko
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Voltage-dependent kappa-opioid modulation of action potential waveform-elicited calcium currents in neurohypophysial terminals.

Authors:  Cristina M Velázquez-Marrero; Héctor G Marrero; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.

Authors:  David Robbe; Gerard Alonso; Severine Chaumont; Joel Bockaert; Olivier J Manzoni
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

4.  AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesia.

Authors:  Fumiko Sekiguchi; Yuka Aoki; Maiko Nakagawa; Daiki Kanaoka; Yuta Nishimoto; Maho Tsubota-Matsunami; Rumi Yamanaka; Shigeru Yoshida; Atsufumi Kawabata
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  μ-Opioid inhibition of Ca2+ currents and secretion in isolated terminals of the neurohypophysis occurs via ryanodine-sensitive Ca2+ stores.

Authors:  Cristina Velázquez-Marrero; Sonia Ortiz-Miranda; Héctor G Marrero; Edward E Custer; Steven N Treistman; José R Lemos
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

Review 6.  The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor.

Authors:  Jeroen Spanoghe; Lars E Larsen; Erine Craey; Simona Manzella; Annelies Van Dycke; Paul Boon; Robrecht Raedt
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.